pqri project update l.
Skip this Video
Loading SlideShow in 5 Seconds..
PQRI Project Update PowerPoint Presentation
Download Presentation
PQRI Project Update

Loading in 2 Seconds...

play fullscreen
1 / 11

PQRI Project Update - PowerPoint PPT Presentation

  • Uploaded on

PQRI Project Update. Fundamental Understanding of Sulfonate Ester-Forming Reactions Date of Original Submission: April 2006 Date of Current Report: February 2009. Background of Work Project.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'PQRI Project Update' - umed

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
pqri project update

PQRI Project Update

Fundamental Understanding of Sulfonate Ester-Forming Reactions

Date of Original Submission: April 2006

Date of Current Report: February 2009

background of work project
Background of Work Project

Concern exists that sulfonate esters may be genotoxic impurities and are potentially formed during drug substance manufacturing when sulfonic acids are used in the presence alcoholic solvents

The elimination of sulfonic acids from drug substance manufacturing would be highly undesirable due to its useful synthetic properties

The amount of sulfonate esters formed under synthetically relevant conditions is currently unclear

objective of work project
Objective of Work Project
  • To scientifically demonstrate that sulfonic acids can safely be used in drug substance manufacturing by
    • Understanding the kinetics of formation and decomposition of sulfonate esters during drug substance manufacture under synthetically relevant conditions
    • Demonstrating that conditions can be manipulated to control the levels of sulfonate esters formed
members of working group
Members of Working Group

Bob Evans, AAPS, synthetic chemist

Sue Jones, PDA, analytical chemist

George Smith, FDA, CDER


status of work project
Status of Work Project
  • Overall work is on time and on budget
  • Stage 1 completed
    • An analytical procedure was developed to monitor ethyl methane sulfonate in ethanol/methane sulfonic acid reaction mixtures
    • The method was found to be sufficiently robust to be used in synthetic studies
  • Stage 2 completed
    • The mechanism of reaction was determined using isotope labeled studies
status of work project6
Status of Work Project
  • Stage 3 underway
    • The kinetics of formation of ethyl methane sulfonate from methane sulfonic acid and ethanol is being studied
    • Thus far the effects of temperature and pH have been evaluated
      • It was determined that decreased amounts of methane sulfonate formed with decreasing temperature and higher pH
      • This is important because it leads to an understanding of process chemistry controls/conditions which minimize or quench methane sulfonate formation
    • Next step is to evaluate the effect of the presence of water (to be completed by June 2009)
impact of work project
Impact of Work Project
  • Based on results obtained thus far, the Working Group believes that this project will positively impact product quality in that
    • Industry will be able to make use of the analytical method and kinetic information to evaluate specific synthetic conditions to determine the extent of sulfonate ester formation in proposed synthetic routes
    • Regulators will have a scientific basis for assessing the appropriateness of synthetic pathways in which sulfonate esters may be formed
communication of work project
Communication of Work Project
  • A paper was submitted to xx on development of the analytical methodology
  • A paper will be submitted to xx on the outcome of the kinetic studies (draft to be available by August 2009)
  • Presentations have been given at conference X and Y
  • An email was sent to all PQRI stakeholders with an update of the project at the end of 2008
  • Are there other opportunities for communication?
  • Total of $200,000 raised for project (70K from PQRI; remainder from member organizations)
  • Thus far $150,000 has been spent; by the end of the project all funds will be consumed
support needed
Support Needed
  • FDA involvement in the WG has waned; is this an important element that should be pursued? Should they be engaged prior to publication?
other opportunities
Other Opportunities?

This work may be extended to other relevant solvent systems

What is the cost/benefit ratio of doing so?